Firering Strategic Minerals: From explorer to producer. Watch the video here.
May i also add, there seems to be [within some groups of people] a general assumption that positive outcome of vaccine for covid19 is a given and that it's just a matter of going through the development process.
History provides different guidance.
The journey to develop a world-beating covid19 vaccine is open season atm with many hurdles to jump.
Probablity ans history suggests, with the exception of fast-tracking a safe vaccine with moderate benefits [pushed forward by political will] a genuine world-beating vaccine [vaccines] will take time and a vast array of knowledge from multiple experts.
And, while all the pharma plough their cash into development, Open Orphan will continue to generate profitable income regardless of outcome.
Open Orphan is at the beginning of its journey [covid and non covid].
I tried cutting the grass two weeks ago, only for the brake cable on the Stiga to snap leading me to take a chunk out of the apple tree.
And, no, the share price didn't go up.
I wont be putting weeding to the test either.
Developing a 'working' version of covid19 is what hVIVO are attempting to do.
Without it, they cannot develop [or sell] a challenge study for covid19.
Adrian Wildfire is yet another specialist in this area.
CF has hired extra talent to achieve this aim while at the same time eliminating all competition.
Also, when i use the word 'hired' i'm using Cathal's phrasing, not mine.
CF mentioned during his recent Hardman & Co. presentation that Adrian Wildfire and team had returned to hVIVO.
Amryt/Imutex?
NO - is the simple answer.
Yep, you have to respect time spent researching. Reduce the risk.
From midnight tomorrow, metropolitan Melbourne and Mitchell Shire, north of Melbourne, will return to stage 3 restrictions for the next six weeks.
Four reasons to leave home: shopping for supplies, compassionate care, exercise and for work or study.
Further supports my guidance on a continued need to push forward with covid and respiratory illness vaccines and medicines.
Orph remains firmly inline to benefit from both, and more besides.
That'll be John Henry investing his unused 2020 holiday fund.
I'll accept transfer of wealth. even from moaning weasels.
Deepjoy, we need a nice short, sharp shock to the price to flesh out the remaining low-hanging investors and force them into capitulation.
Soon enough we'll be left with a company heading in the right direction within a cash-backed sector with only buyers remaining.
CF already hinted - verbally - at the minimal value of lab service contracts.
These contracts are important in that they use existing untapped resource, meaning that majority revenue goes straight to bottom line.
Yes, if not already forward sold.
Maurice is waiting for a share price of 25p, 35p and 45p before exercising his 7+ million share options.
I suggest investors consider doing likewise before fretting over well documented warrants.
Lots of news in today's RNS.
Good to see CF focused to build covid and non-covid business
"NoBACZ Ltd is working with hVIVO, at its state-of-the-art laboratory in East London, to test its products against a range of viruses, including coronaviruses and ultimately, against SARS-CoV-2, the virus strain that causes COVID-19 disease. If successful, the long-lasting coating can be applied to high-touch surfaces in public transport, office buildings, hospitals, gyms, care-homes, and supermarkets."
Deepjoy, they didn't get the joke.
Probably because they were the butt of the joke.
Price parked on the 50ma with weak trading volume.
Market waiting for confirmation of continued progress. Price holding up fairly well, considering.
Looking back, i expect July 2020 will be seen as prime period to buy Orph.
Come Autumn i suspect this will be a different animal.
No, they've just changed the URL.
You can alwayss read the news release on Quotient's website:
https://www.quotientbd.com/news/honeyman-group-launches-mosaiq-antibody-testing-platform-covid-19
yeh! ... another overhang comment.
wow! so, that's sorted then. phew!
Orph presents incredible upside for investors.
DYOR.
Deepjoy doesn't have a local valid fishing license.
Is that someone you want to trust?